Chesapeake Wealth Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.77M | Buy |
14,755
+15
| +0.1% | +$1.73K | 0.54% | 53 |
|
|
2025
Q4 | $1.55M | Buy |
14,740
+87
| +0.6% | +$8.17K | 0.46% | 59 |
|
|
2025
Q3 | $1.23M | Sell |
14,653
-386
| -3% | -$31.8K | 0.38% | 67 |
|
|
2025
Q2 | $1.19M | Sell |
15,039
-689
| -4% | -$54.8K | 0.4% | 64 |
|
|
2025
Q1 | $1.41M | Sell |
15,728
-450
| -3% | -$42K | 0.5% | 58 |
|
|
2024
Q4 | $1.61M | Sell |
16,178
-183
| -1% | -$18.9K | 0.55% | 52 |
|
|
2024
Q3 | $1.86M | Buy |
16,361
+244
| +2% | +$29K | 0.63% | 49 |
|
|
2024
Q2 | $2M | Sell |
16,117
-555
| -3% | -$71.5K | 0.72% | 46 |
|
|
2024
Q1 | $2.2M | Buy |
16,672
+206
| +1% | +$25.4K | 0.8% | 44 |
|
|
2023
Q4 | $1.8M | Sell |
16,466
-342
| -2% | -$35.5K | 0.69% | 47 |
|
|
2023
Q3 | $1.73M | Buy |
16,808
+16
| +0.1% | +$1.73K | 0.72% | 46 |
|
|
2023
Q2 | $1.94M | Buy |
16,792
+654
| +4% | +$74.3K | 0.76% | 42 |
|
|
2023
Q1 | $1.72M | Buy |
16,138
+781
| +5% | +$84.3K | 0.72% | 41 |
|
|
2022
Q4 | $1.7M | Buy |
15,357
+2,200
| +17% | +$225K | 0.75% | 42 |
|
|
2022
Q3 | $1.13M | Buy |
13,157
+6,970
| +113% | +$622K | 0.52% | 55 |
|
|
2022
Q2 | $564K | Buy |
6,187
+473
| +8% | +$41.9K | 0.24% | 99 |
|
|
2022
Q1 | $469K | Sell |
5,714
-541
| -9% | -$42.7K | 0.17% | 121 |
|
|
2021
Q4 | $479K | Buy |
6,255
+19
| +0.3% | +$1.51K | 0.16% | 128 |
|
|
2021
Q3 | $469K | Sell |
6,236
-825
| -12% | -$62.7K | 0.17% | 125 |
|
|
2021
Q2 | $549K | Sell |
7,061
-782
| -10% | -$58.2K | 0.18% | 124 |
|
|
2021
Q1 | $577K | Sell |
7,843
-5,585
| -42% | -$412K | 0.19% | 116 |
|
|
2020
Q4 | $1.05M | Sell |
13,428
-2,284
| -15% | -$175K | 0.36% | 81 |
|
|
2020
Q3 | $1.24M | Sell |
15,712
-6,332
| -29% | -$496K | 0.46% | 62 |
|
|
2020
Q2 | $1.63M | Sell |
22,044
-4,116
| -16% | -$310K | 0.65% | 35 |
|
|
2020
Q1 | $1.92M | Buy |
26,160
+158
| +0.6% | +$12.4K | 0.89% | 23 |
|
|
2019
Q4 | $2.26M | Buy |
26,002
+1,281
| +5% | +$105K | 0.87% | 24 |
|
|
2019
Q3 | $1.99M | Buy |
24,721
+503
| +2% | +$40.3K | 0.81% | 27 |
|
|
2019
Q2 | $1.94M | Buy |
24,218
+2,539
| +12% | +$194K | 0.81% | 27 |
|
|
2019
Q1 | $1.72M | Buy |
21,679
+1,679
| +8% | +$126K | 0.76% | 29 |
|
|
2018
Q4 | $1.46M | Buy |
20,000
+3,454
| +21% | +$244K | 0.72% | 35 |
|
|
2018
Q3 | $1.12M | Buy |
16,546
+703
| +4% | +$44.8K | 0.5% | 54 |
|
|
2018
Q2 | $917K | Buy |
15,843
+2,512
| +19% | +$142K | 0.42% | 63 |
|
|
2018
Q1 | $693K | Buy |
+13,331
| New | +$720K | 0.32% | 87 |
|
Other funds holding MRK
VCM
VPM
Chesapeake Wealth Management's MRK Position: Q1 2026 in Review
Chesapeake Wealth Management increased its Merck (MRK) stake by 0.1% in Q1 2026, buying an estimated $1.73K and bringing the position to 14,755 shares worth $1.77M. The position accounts for 0.54% of the portfolio, ranked #53.
Chesapeake Wealth Management first reported a position in MRK in Q1 2018 and has held it in 33 quarters since. The position peaked at $2.26M in Q4 2019. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Chesapeake Wealth Management held 14,755 shares of Merck worth $1.77M as of Q1 2026.
- Chesapeake Wealth Management bought 15 Merck shares in Q1 2026, an estimated $1.73K.
- Merck made up 0.54% of Chesapeake Wealth Management's portfolio in Q1 2026, its #53 holding.
- Chesapeake Wealth Management first reported a position in Merck in Q1 2018 and has held it in 33 quarters since.
- Chesapeake Wealth Management's Merck position peaked at $2.26M in Q4 2019.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Chesapeake Wealth Management's 13F filing for Q1 2026, filed 18 May 2026.